Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Report 2025

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Ribonucleic Acid (RNA)-Based Oncolytic Therapy Global Market Report 2025

Name: Ribonucleic Acid (RNA)-Based Oncolytic Therapy Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Therapy Type (Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy, Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy, Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy, Other Therapy Types); By Route Of Administration (Intravenous, Intratumoral, Other Route Of Administrations); By Application (Breast Cancer, Other Applications); By End-User (Hospitals, Cancer Research Institutes, Other End-Users); By Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy (Chemically Modified siRNA); By Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy (miRNA Mimics, miRNA Inhibitors (Antagomirs)); By Other Therapy Types (Long Non-Coding RNA (lncRNA)-Based Therapies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

• Ribonucleic Acid (RNA)-Based Oncolytic Therapy market size has reached to $1.78 billion in 2024

• Expected to grow to $4.17 billion in 2029 at a compound annual growth rate (CAGR) of 18.5%

• Growth Driver: Growing Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To Increasing Demand For Targeted And Patient-specific Treatments

• Market Trend: Innovations In mRNA-Lipid Nanoparticle Delivery Systems Boosting Market Growth

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market?

Ribonucleic acid (RNA)-based oncolytic therapy is a cancer treatment that uses engineered RNA viruses to selectively infect and kill tumor cells. These viruses replicate in cancer cells, causing their destruction and releasing tumor antigens. This also stimulates the immune system to recognize and attack remaining cancer cells, enhancing overall anti-tumor efficacy.

The main therapy types of ribonucleic acid (RNA)-based oncolytic therapy are messenger ribonucleic acid (mRNA)-based oncolytic therapy, small interfering ribonucleic acid (siRNA)-based oncolytic therapy, micro ribonucleic acid (miRNA)-based oncolytic therapy, and other therapy types. Messenger ribonucleic acid (mRNA)-based oncolytic therapy refers to the use of synthetic mRNA molecules engineered to stimulate the immune system or directly induce tumor cell death, offering a targeted and adaptable approach to cancer treatment. These therapies are administered through routes such as Intravenous, Intratumoral, and other methods, and are applied in breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, and others. The key end-users include hospitals, cancer research institutes, specialty clinics, and others.

Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Size and growth rate 2025 to 2029: Graph

What Is The Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Size 2025 And Growth Rate?

What Is The Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Growth Forecast?

The ribonucleic acid (RNA)-based oncolytic therapy market size is expected to see rapid growth in the next few years. It will grow to $4.17 billion in 2029 at a compound annual growth rate (CAGR) of 18.5%. The growth in the forecast period can be attributed to increasing adoption of RNA-based therapies, growing focus on immuno-oncology, rising biotechnology collaborations, expansion of advanced manufacturing facilities, and increasing access to precision medicine. Major trends in the forecast period include technological advancements, developments in viral vector design, investment in research and development, innovation in delivery systems, and development of combination therapy approaches.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How the Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Segmented?

1) By Therapy Type: Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy, Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy, Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy, Other Therapy Types

2) By Route Of Administration: Intravenous, Intratumoral, Other Route Of Administrations

3) By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Applications

4) By End-User: Hospitals, Cancer Research Institutes, Specialty Clinics, Other End-Users

Subsegment:

1) By Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy: Self-Amplifying mRNA (saRNA), Non-Replicating mRNA, Circular RNA (circRNA)-Based mRNA therapy

2) By Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy: Chemically Modified siRNA, Nanoparticle-Delivered siRNA, Conjugated siRNA

3) By Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy: miRNA Mimics, miRNA Inhibitors (Antagomirs), miRNA Aponges Or Decoys

4) By Other Therapy Types: Long Non-Coding RNA (lncRNA)-Based Therapies, Short Hairpin RNA (shRNA)-Based Therapies, Aptamer-RNA Based Oncolytic Agents

What Is Driving The Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market? Growing Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To Increasing Demand For Targeted And Patient-specific Treatments

The growing adoption of personalized medicine is expected to propel the growth of the RNA-based oncolytic therapy market going forward. Personalized medicine refers to medical treatments tailored to individual genetic profiles, improving efficacy and reducing adverse effects. The adoption of personalized medicine is increasing as more healthcare providers and institutions recognize the potential to enhance patient outcomes through targeted therapies and precision diagnostics. RNA-based oncolytic therapy plays a crucial role in cancer care by aligning with the growing adoption of personalized medicine to deliver targeted and patient-specific treatment approaches. For instance, in February 2024, the Personalized Medicine Coalition, a US-based advocacy group for tailored medical treatments, the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from 6 in 2022. Therefore, the growing adoption of personalized medicine is driving the RNA-based oncolytic therapy market.

Who Are The Major Players In The Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market?

Major companies operating in the ribonucleic acid (rna)-based oncolytic therapy market are AstraZeneca PLC, Moderna Inc., BioNTech SE, Gritstone Bio Inc., Orna Therapeutics Inc., Strand Therapeutics Inc., Oncolytics Biotech Inc., Anima Biotech Inc., eTheRNA immunotherapies NV, Vyriad Inc., Haya Therapeutics Inc., Virogin Biotech Inc., Providence Therapeutics Holdings Inc., Sirnaomics Inc., Humane Genomics Inc., Replicate Bioscience Inc., Abogen Biosciences Inc., Chimeron Bio Inc., Aro Biotherapeutics Inc., TransCode Therapeutics Inc.

What Are The Key Trends Of The Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market? Innovations In mRNA-Lipid Nanoparticle Delivery Systems Boosting Market Growth

Major companies are operating in the ribonucleic acid (RNA)-based oncolytic therapy market, focusing on developing technological advancements such as synthetic messenger RNA (mRNA) technology to enhance tumor-targeting efficiency, improve immune activation, and achieve more precise and durable cancer treatment outcomes. Synthetic messenger RNA (mRNA) technology is a biotechnology approach that designs and delivers lab-made mRNA sequences to direct cells to produce specific therapeutic proteins for disease treatment, including cancer. For instance, in June 2024, CSPC Pharmaceutical Group Limited, a China-based pharmaceutical company, received regulatory approval in China to initiate clinical trials for SYS6020, its synthetic mRNA-based cancer cell therapy. This development represents a major advancement in the country’s messenger RNA therapeutics landscape. SYS6020 employs mRNA-lipid nanoparticle technology to selectively target and eliminate myeloma cancer cells with minimal adverse effects, while also demonstrating potential applications in the treatment of certain autoimmune diseases.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market? Lyndra Therapeutics Partners With Thermo Fisher To Advance Long-Acting Oral Therapies Including Weekly Risperidone

In June 2023, Charles River Laboratories International, Inc., a US-based contract research organization (CRO), partnered with Curigin Co., Ltd. to produce oncolytic RNAi gene therapy. With this collaboration, the aim is to advance the development and manufacturing of Curigin’s RNAi-based oncolytic gene therapies by leveraging Charles River’s CDMO expertise to support preclinical and clinical trials. Curigin Co. Ltd. is a South Korea-based biotechnology company specializing in the development of RNA interference (RNAi)-based oncolytic gene therapies for cancer treatment.

What Is The Regional Outlook For The Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market?

North America was the largest region in the ribonucleic acid (RNA)-based oncolytic therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market?

The ribonucleic acid (RNA)-based oncolytic therapy market includes revenues earned by entities through services such as clinical trials, tumor targeting, immune monitoring, patient support, and treatment administration. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribonucleic acid (RNA)-based oncolytic therapy market also includes sales of RNA oncolytic viruses, viral vectors, delivery systems, formulations, and diagnostic kits. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Ribonucleic Acid (RNA)-Based Oncolytic Therapy Industry?

The ribonucleic acid (rna)-based oncolytic therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna)-based oncolytic therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

1. Executive Summary

2. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Characteristics

3. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Trends And Strategies

4. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Growth Rate Analysis

5.4. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Total Addressable Market (TAM)

6. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Segmentation

6.1. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy

Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy

Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy

Other Therapy Types

6.2. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravenous

Intratumoral

Other Route Of Administrations

6.3. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Melanoma

Other Applications

6.4. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Cancer Research Institutes

Specialty Clinics

Other End-Users

6.5. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Self-Amplifying mRNA (saRNA)

Non-Replicating mRNA

Circular RNA (circRNA)-Based mRNA Therapy

6.6. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chemically Modified siRNA

Nanoparticle-Delivered siRNA

Conjugated siRNA

6.7. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

miRNA Mimics

miRNA Inhibitors (Antagomirs)

miRNA Sponges Or Decoys

6.8. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Long Non-Coding RNA (lncRNA)-Based Therapies

Short Hairpin RNA (shRNA)-Based Therapies

Aptamer-RNA Based Oncolytic Agents

7. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Regional And Country Analysis

7.1. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

8.1. Asia-Pacific Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

9.1. China Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

9.2. China Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

10.1. India Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

11.1. Japan Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

11.2. Japan Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

12.1. Australia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

13.1. Indonesia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

14.1. South Korea Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

14.2. South Korea Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

15.1. Western Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

15.2. Western Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

16.1. UK Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

17.1. Germany Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

18.1. France Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

19.1. Italy Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

20.1. Spain Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

21.1. Eastern Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

21.2. Eastern Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

22.1. Russia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

23.1. North America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

23.2. North America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

24.1. USA Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

24.2. USA Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

25.1. Canada Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

25.2. Canada Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

26.1. South America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

26.2. South America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

27.1. Brazil Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

28.1. Middle East Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

28.2. Middle East Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

29.1. Africa Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Overview

29.2. Africa Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Competitive Landscape And Company Profiles

30.1. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Competitive Landscape

30.2. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Company Profiles

30.2.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. BioNTech SE Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Gritstone Bio Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Orna Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Other Major And Innovative Companies

31.1. Strand Therapeutics Inc.

31.2. Oncolytics Biotech Inc.

31.3. Anima Biotech Inc.

31.4. eTheRNA immunotherapies NV

31.5. Vyriad Inc.

31.6. Haya Therapeutics Inc.

31.7. Virogin Biotech Inc.

31.8. Providence Therapeutics Holdings Inc.

31.9. Sirnaomics Inc.

31.10. Humane Genomics Inc.

31.11. Replicate Bioscience Inc.

31.12. Abogen Biosciences Inc.

31.13. Chimeron Bio Inc.

31.14. Aro Biotherapeutics Inc.

31.15. TransCode Therapeutics Inc.

32. Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

34. Recent Developments In The Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market

35. Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market High Potential Countries, Segments and Strategies

35.1 Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market In 2029 - Countries Offering Most New Opportunities

35.2 Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market In 2029 - Segments Offering Most New Opportunities

35.3 Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: AstraZeneca PLC Financial Performance

Table 80: Moderna Inc. Financial Performance

Table 81: BioNTech SE Financial Performance

Table 82: Gritstone Bio Inc. Financial Performance

Table 83: Orna Therapeutics Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation OfSmall Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: AstraZeneca PLC Financial Performance

Figure 80: Moderna Inc. Financial Performance

Figure 81: BioNTech SE Financial Performance

Figure 82: Gritstone Bio Inc. Financial Performance

Figure 83: Orna Therapeutics Inc. Financial Performance

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Oncolytic Virus Therapy Global Market Report 2025 – By Therapy Type (HSV-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, NDV (Newcastle Disease Virus), Other Therapy Types),...

Nucleic Acid Based Gene Therapy Global Market Report 2025 – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies), By App...

mRNA Cancer Vaccines And Therapeutics Global Market Report 2025 – By Type (Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas), By Application (Infectious Disease, Cancer, Other Applications), By End User (H...

mRNA Therapeutics Global Market Report 2025 – By Product (Vaccines, Drugs), By Application (Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications), By End Use (Hospitals And Clini...

RNA Targeting Small Molecules Therapeutics Global Market Report 2025 – By Offering (mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Ta...

Antisense & RNAi Therapeutics Global Market Report 2025 – By Technology (RNA Interference, Antisense RNA), By Route of Administration (Intravenous Injections, Intra-dermal Injections, Other Delivery Methods), By Indicati...

Oligonucleotide Therapy Global Market Report 2025 – By Type (Antisense Oligonucleotide, Aptamer, Other Types), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney D...

Frequently Asked Questions

What is the definition of the Ribonucleic Acid (RNA)-Based Oncolytic Therapy market?

How will the Ribonucleic Acid (RNA)-Based Oncolytic Therapy market drivers and restraints affect the market dynamics? What forces will shape the Ribonucleic Acid (RNA)-Based Oncolytic Therapy industry going forward?

The market major growth driver - Growing Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To Increasing Demand For Targeted And Patient-specific Treatments. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Ribonucleic Acid (RNA)-Based Oncolytic Therapy market?

The ribonucleic acid (RNA)-based oncolytic therapy market size has grown rapidly in recent years. It will grow from $1.78 billion in 2024 to $2.12 billion in 2025 at a compound annual growth rate (CAGR) of 18.9%. The growth in the historic period can be attributed to increasing cancer prevalence, rising investment in healthcare infrastructure, growing awareness of targeted therapies, expansion of clinical trial programs, and increasing government funding for oncology research. The ribonucleic acid (RNA)-based oncolytic therapy market size is expected to see rapid growth in the next few years. It will grow to $4.17 billion in 2029 at a compound annual growth rate (CAGR) of 18.5%. The growth in the forecast period can be attributed to increasing adoption of RNA-based therapies, growing focus on immuno-oncology, rising biotechnology collaborations, expansion of advanced manufacturing facilities, and increasing access to precision medicine. Major trends in the forecast period include technological advancements, developments in viral vector design, investment in research and development, innovation in delivery systems, and development of combination therapy approaches. For further insights on this market, request a sample here

How is the Ribonucleic Acid (RNA)-Based Oncolytic Therapy market segmented?

The ribonucleic acid (RN)-based oncolytic therapy market covered in this report is segmented as
1) By Therapy Type: Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy, Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy, Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy, Other Therapy Types
2) By Route Of Administration: Intravenous, Intratumoral, Other Route Of Administrations
3) By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Applications
4) By End-User: Hospitals, Cancer Research Institutes, Specialty Clinics, Other End-Users Subsegment:
1) By Messenger Ribonucleic Acid (mRNA)-Based Oncolytic Therapy: Self-Amplifying mRNA (saRNA), Non-Replicating mRNA, Circular RNA (circRNA)-Based mRNA therapy
2) By Small Interfering Ribonucleic Acid (siRNA)-Based Oncolytic Therapy: Chemically Modified siRNA, Nanoparticle-Delivered siRNA, Conjugated siRNA
3) By Micro Ribonucleic Acid (miRNA)-Based Oncolytic Therapy: miRNA Mimics, miRNA Inhibitors (Antagomirs), miRNA Aponges Or Decoys
4) By Other Therapy Types: Long Non-Coding RNA (lncRNA)-Based Therapies, Short Hairpin RNA (shRNA)-Based Therapies, Aptamer-RNA Based Oncolytic Agents For further insights on this market, request a sample here

Which region has the largest share of the Ribonucleic Acid (RNA)-Based Oncolytic Therapy market? What are the other regions covered in the report?

North America was the largest region in the ribonucleic acid (RNA)-based oncolytic therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ribonucleic acid (RNA)-based oncolytic therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Who are the major players in the Ribonucleic Acid (RNA)-Based Oncolytic Therapy market?

What are the key trends in the Ribonucleic Acid (RNA)-Based Oncolytic Therapy market?

Major trends in this market include Innovations In mRNA-Lipid Nanoparticle Delivery Systems Boosting Market Growth For further insights on this market, request a sample here.